Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market Cambridge, UK – 4basebio PLC (AIM: 4BB) (“4basebio”), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. […]
Saint-Germain-en-Laye, France – Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL (MN), a leading global provider of analytical and bioanalytical products. Under this agreement, Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxemburg, Sweden, Switzerland and the United Kingdom. MN’s Bioanalysis […]
Genovis AB (publ) (“Genovis”) today announces that it has exercised its call option to acquire the remaining 75% of SEQURNA AB (“SEQURNA” or “Company”), a strategic move that accelerates Genovis’ expansion into the fast-growing genomics sector. This acquisition unlocks new product offerings for Genovis to both existing and new customers and further paves the way […]
Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market STOCKHOLM — Epigenica AB, a pioneer in high-throughput epigenetic screening tools and solutions, announced today that it has closed a $2.2 million round (SEK 21.5M) to fuel its growth and commercial expansion across key markets. This round was led by Voima Ventures, a Nordic early-stage […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer. This appointment marks a pivotal step in Danaher’s digital transformation and its ambition to lead the […]
WASHINGTON — Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President and Group Executive of the […]
Stephen H. Rusckowski elected as Chairman of the Supervisory Board after AGM; former Chairman Lawrence A. Rosen did not stand for re-election following 12 years of service Shareholders approve all resolutions at AGM – including first-ever annual cash dividend and a synthetic share repurchase authorization of up to $500 million VENLO, Netherlands — QIAGEN N.V. […]
In the study of rare diseases and precision medicine, understanding gene expression in the spatial context of tissues is essential. High-throughput sequencing and STOmics technology will enhance biological and molecular understanding of various pathologies. MILAN — MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced a […]
Transaction Set to Close in July Synthego Solidly Positioned for Expansion & Growth Redwood City, CA — Synthego, a leading provider of CRISPR solutions, today confirmed that its sale to Perceptive Advisors, a global life sciences investor known for backing leading biotech companies, is cleared to close. This transaction, expected to close in July, will […]
FREMONT, Calif. — Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that its UG 100 ™ sequencing platform has been selected to support Regeneron Genetics Center® (RGC™) and its recently launched U.S. large-scale proteomics study. The study, comprised of 200,000 blood serum samples secured by RGC from its long-standing research collaboration with Geisinger Health System, will be […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
